Vivispray 1 mg/ml sprej za nos, otopina
| Name | Vivispray 1 mg/ml sprej za nos, otopina |
|---|---|
| Marketing Authorisation Number | HR-H-241761496 |
| Active Substance | azelastinklorid |
| Composition | 1 ml otopine sadrži 1 mg azelastinklorida jedna potisak (0,14 ml) sadrži 0,14 mg azelastinklorida, što odgovara 0,13 mg azelastina |
| Pharmaceutical Form | sprej za nos, otopina |
| Manufacturer | SAG Manufacturing S.L.U., San Agustin del Guadalix, Madrid, Španjolska Galenicum Health S.L., Barcelona, Španjolska |
| Marketing Authorisation Holder | Bausch + Lomb Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 25.10.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/229 |
| Registration Number | 381-12-01/70-22-04 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | R01AC03 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
